Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration

Sponsor
University Health Network, Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT00329277
Collaborator
(none)
30
1
21
1.4

Study Details

Study Description

Brief Summary

Standard perimetry provides information on topographical retinal sensitivity to light stimuli, however the said locus is not necessarily the preferred locus for fixation. Standard perimetry could also be used as a way for macular scotoma mapping, indirectly showing the fixation locus. Topographic acuity at the preferred retinal locus can be determined if correlation between loci with high sensitivity, eccentric fixation loci and potential visual acuity measurements are correlated.

PURPOSE OF THE STUDY:

Determination of visual acuity at preferred retinal locus in Low Vision patients with ARMD using eye standard automated and computerized perimetry methods.

Condition or Disease Intervention/Treatment Phase
  • Procedure: perimetry
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Study Start Date :
Apr 1, 2006
Actual Primary Completion Date :
Jan 1, 2008
Actual Study Completion Date :
Jan 1, 2008

Outcome Measures

Primary Outcome Measures

  1. Location of eccentric retinal locus of highest fixation accuracy []

Secondary Outcome Measures

  1. Location of eccentric locus with best retinal sensitivity []

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • AMD with documented pathology

  • Low Vision both eyes

  • BCVA 20/50-20/400 in best eye

Exclusion Criteria:
  • Cognitive impairment

  • Other retinal pathology

  • Previous retinal surgery

  • Significant media opacity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dr S N Markowitz Toronto Ontario Canada M6H 2H1

Sponsors and Collaborators

  • University Health Network, Toronto

Investigators

  • Principal Investigator: Samuel Markowitz, MD, University Health Network, Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00329277
Other Study ID Numbers:
  • SNM200601
First Posted:
May 24, 2006
Last Update Posted:
May 28, 2008
Last Verified:
Nov 1, 2006
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 28, 2008